Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers. (28th November 2015)
- Record Type:
- Journal Article
- Title:
- Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers. (28th November 2015)
- Main Title:
- Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers
- Authors:
- Elborai, Yasser
Hafez, Hanafy
Moussa, Emad A.
Hammad, Mahmoud
Hussein, Hany
Lehmann, Leslie
Elhaddad, Alaa - Abstract:
- Abstract: The outcome for advanced neuroblastoma has improved with combined modality therapy: induction chemotherapy, surgery, and consolidation with high‐dose chemotherapy/autologous HSCT, followed by local radiation, cisretinoic acid, and recently antibody therapy. In the United States, the most common conditioning regimen is CEM, while in Europe/Middle East, Bu/Mel has been widely used; it remains unclear which regimen has the best outcome. Assess renal, hepatic, and infectious toxicity through Day+100 in 2 different regimens. Retrospective comparison between CEM‐DFCHCC Boston and Bu/Mel‐ CCHE‐57357. Thirty‐five patients, median age 4, in Boston (2007–2011) and 38 patients, median age 3, in Cairo (2009–2011). Renal toxicity; creatinine was significantly higher in CEM than Bu/Mel: 57% (median day+90) vs. 29% (median>day+100), p = 0.004. One CEM patient died from renal dialysis at day+19. Hepatic toxicity was significantly higher in CEM than Bu/Mel: 80% (median day+26) vs. 58% (median day+60), p = 0.04. In infectious complications with CEM 14%, bacteremia (n = 4) and fungemia (n = 1), 3 had culture‐negative sepsis requiring vasopressors. With Bu/Mel 18%, bacteremia (n = 7), none required pressors, p = 0.4. Bu/Mel was associated with less acute hepatic and renal toxicity and thus may be preferable for preserving organ functions.
- Is Part Of:
- Pediatric transplantation. Volume 20:Number 2(2016:Mar.)
- Journal:
- Pediatric transplantation
- Issue:
- Volume 20:Number 2(2016:Mar.)
- Issue Display:
- Volume 20, Issue 2 (2016)
- Year:
- 2016
- Volume:
- 20
- Issue:
- 2
- Issue Sort Value:
- 2016-0020-0002-0000
- Page Start:
- 284
- Page End:
- 289
- Publication Date:
- 2015-11-28
- Subjects:
- neuroblastoma -- autologous hematopoietic stem cell transplantation (HSCT) -- carboplatin -- etoposide -- melphalan (CEM) -- busulfan/melphalan (Bu/Mel) -- renal toxicity
Transplantation of organs, tissues, etc. in children -- Periodicals
617.95408305 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=ptr ↗
http://www.blackwellpublishing.com/journal.asp?ref=1397-3142&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1399-3046 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/petr.12638 ↗
- Languages:
- English
- ISSNs:
- 1397-3142
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6417.628330
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 958.xml